Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.21.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenues:    
Total revenues $ 18,032 $ 14,670
Costs and operating expenses:    
Cost of product revenue 4,218 2,541
Research and development 11,571 10,967
Selling, general and administrative 11,398 8,989
Total costs and operating expenses 27,187 22,497
Loss from operations (9,155) (7,827)
Interest income 177 266
Other expenses, net (88) (86)
Loss before income taxes (9,066) (7,647)
Provision for income taxes 2 5
Net loss $ (9,068) $ (7,652)
Net income (loss) per share, basic (usd per share) $ (0.14) $ (0.13)
Net income (loss) per share, diluted (usd per share) $ (0.14) $ (0.13)
Weighted average common stock shares used in computing net income (loss) per share, basic (shares) 64,290,000 58,888,000
Weighted average common stock shares used in computing net income (loss) per share, diluted (shares) 64,290,000 58,888,000
Product Revenue [Member]    
Revenues:    
Total revenues $ 10,226 $ 5,100
Research and Development Revenue [Member]    
Revenues:    
Total revenues $ 7,806 $ 9,570